Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3771125012 | Loteprednol and tobramycin only product in ocular dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
3771126013 | Product containing only loteprednol and tobramycin in ocular dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Loteprednol and tobramycin only product in ocular dose form | Is a | Loteprednol and tobramycin only product | true | Inferred relationship | Some | ||
Loteprednol and tobramycin only product in ocular dose form | Is a | Loteprednol- and tobramycin-containing product in ocular dose form | true | Inferred relationship | Some | ||
Loteprednol and tobramycin only product in ocular dose form | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
Loteprednol and tobramycin only product in ocular dose form | Has manufactured dose form | Ocular dose form | true | Inferred relationship | Some | ||
Loteprednol and tobramycin only product in ocular dose form | Has active ingredient | Tobramycin | true | Inferred relationship | Some | 1 | |
Loteprednol and tobramycin only product in ocular dose form | Has active ingredient | Loteprednol | true | Inferred relationship | Some | 2 | |
Loteprednol and tobramycin only product in ocular dose form | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Loteprednol etabonate 5 mg/mL and tobramycin 3 mg/mL eye suspension | Is a | True | Loteprednol and tobramycin only product in ocular dose form | Inferred relationship | Some |
This concept is not in any reference sets